Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist

被引：7

作者：

Fabrizi, F ^{[1
]}

Locatelli, F ^{[1
]}

机构：

[1] Azienda Osped Lecco, Div Nephrol & Dialysis, I-23900 Lecce, Italy

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1999年 / 14卷 / 09期

关键词：

D O I：

10.1093/ndt/14.9.2079

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：2079 / 2081

页数：3

共 10 条

[1] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C [J].

Davis, GL ;

Esteban-Mur, R ;

Rustgi, V ;

Hoefs, J ;

Gordon, SC ;

Trepo, C ;

Shiffman, ML ;

Zeuzem, S ;

Craxi, A ;

Ling, MH ;

Albrecht, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1493-1499

[2] Treatment of hepatitis C infection in patients with renal disease [J].

Diego, JM ;

Roth, D .

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1998, 7 (05) :557-562

[3] INTERFERON-ALPHA FACILITATES RENAL-TRANSPLANTATION IN HEMODIALYSIS-PATIENTS WITH CHRONIC VIRAL-HEPATITIS [J].

DUARTE, R ;

HURAIB, S ;

SAID, R ;

ABDELKHADIR, A ;

SULLIVAN, S ;

CHABALLOUT, A ;

SBEIH, F ;

MUGHAL, T .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (01) :40-45

[4] A double-blind controlled trial of recombinant interferon-alpha 2b in haemodialysis patients with chronic hepatitis C virus infection and abnormal aminotransferase levels [J].

Fernandez, JL ;

Rendo, P ;

delPino, N ;

Cavalli, N ;

Cusumano, A ;

Digioia, M ;

Molteni, JL ;

Lef, L ;

Nader, E ;

Otino, F ;

Santos, JC ;

Zucchini, A ;

Viola, L .

JOURNAL OF VIRAL HEPATITIS, 1997, 4 (02) :113-119

[5]

GRAZIANI G, 1998, GIORN IT NEFROL, V15, P191

[6] Impact of hepatitis B and C virus on kidney transplantation outcome [J].

Mathurin, P ;

Mouquet, C ;

Poynard, T ;

Sylla, C ;

Benalia, H ;

Fretz, C ;

Thibault, V ;

Cadranel, JF ;

Bernard, B ;

Opolon, P ;

Coriat, P ;

Bitker, MO .

HEPATOLOGY, 1999, 29 (01) :257-263

[7] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C [J].

McHutchison, JG ;

Gordon, SC ;

Schiff, ER ;

Shiffman, ML ;

Lee, WM ;

Rustgi, VK ;

Goodman, ZD ;

Ling, MH ;

Cort, S ;

Albrecht, JK .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1485-1492

[8]

PATTERSON JL, 1990, REV INFECT DIS, V12, P1139

[9] Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus [J].

Poynard, T ;

Marcellin, P ;

Lee, SS ;

Niederau, C ;

Minuk, GS ;

Ideo, G ;

Bain, V ;

Heathcote, J ;

Zeuzem, S ;

Trepo, C ;

Albrecht, J .

LANCET, 1998, 352 (9138) :1426-1432

[10]

Rostaing L, 1998, J AM SOC NEPHROL, V9, P2344

← 1 →